Maravai Lifesciences Holdings, Inc.
MRVINasdaqCIK 1823239HealthcareFiscal year ends Dec 31
Reports and events: 90 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0720:03 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001823239-26-000059 |
| 2026-08-0620:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001823239-26-000056 |
| 2026-06-0312:31 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001823239-26-000049 |
| 2026-05-2920:19 ET | 8-K | 5.07 Shareholder vote results | 0001823239-26-000046 |
| 2026-05-0820:30 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001823239-26-000024 |
| 2026-05-0720:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001823239-26-000022 |
| 2026-04-2420:29 ET | DEF 14A | Proxy statementPeriod 2026-05-26 | 0001823239-26-000014 |
| 2026-02-2621:06 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001823239-26-000011 |
| 2026-02-2521:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001823239-26-000005 |
| 2025-11-0721:21 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001823239-25-000120 |
| 2025-11-0621:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001823239-25-000117 |
| 2025-10-2720:23 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001823239-25-000113 |
| 2025-08-1121:02 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001823239-25-000107 |
| 2025-08-1120:06 ET | 8-K | 2.02 Results of operations; 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001823239-25-000105 |
| 2025-07-1820:45 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001823239-25-000099 |
| 2025-06-2520:13 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-146905 |
| 2025-06-0912:40 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-137478 |
| 2025-05-2821:26 ET | 8-K | 5.07 Shareholder vote results | 0001823239-25-000065 |
| 2025-05-1220:28 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001823239-25-000063 |
| 2025-05-1220:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001823239-25-000062 |
| 2025-04-1820:06 ET | DEF 14A | Proxy statementPeriod 2025-05-22 | 0001193125-25-085761 |
| 2025-03-2020:34 ET | 8-K | 7.01 Regulation FD disclosure | 0001823239-25-000059 |
| 2025-03-1820:09 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001823239-25-000034 |
| 2025-03-1820:08 ET | 8-K | 2.02 Results of operations; 4.02 Non-reliance on financial statements; 9.01 Financial statements and exhibits | 0001823239-25-000033 |
| 2025-02-2501:43 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001823239-25-000028 |
| 2025-01-0821:12 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors | 0001823239-25-000002 |
| 2024-12-1821:35 ET | 8-K | 8.01 Other events | 0001823239-24-000133 |
| 2024-12-0521:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001823239-24-000124 |
| 2024-11-1222:24 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001823239-24-000118 |
| 2024-11-0721:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001823239-24-000105 |
| 2024-09-1219:58 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001823239-24-000100 |
| 2024-08-0820:06 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001823239-24-000095 |
| 2024-08-0720:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001823239-24-000093 |
| 2024-07-2920:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001823239-24-000091 |
| 2024-06-1222:23 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001823239-24-000084 |
| 2024-05-2821:19 ET | 8-K | 5.07 Shareholder vote results | 0001823239-24-000082 |
| 2024-05-0920:44 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001823239-24-000060 |
| 2024-05-0820:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001823239-24-000058 |
| 2024-04-2520:41 ET | DEF 14A | Proxy statementPeriod 2024-05-23 | 0001193125-24-114058 |
| 2024-02-2922:05 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001823239-24-000032 |
| 2024-02-2221:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001823239-24-000028 |
| 2023-11-0822:28 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001823239-23-000089 |
| 2023-11-0721:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001823239-23-000087 |
| 2023-08-0820:20 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001823239-23-000081 |
| 2023-08-0720:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001823239-23-000079 |
| 2023-07-2720:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001823239-23-000077 |
| 2023-07-2020:08 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001823239-23-000072 |
| 2023-05-2220:04 ET | 8-K | 5.07 Shareholder vote results | 0001823239-23-000041 |
| 2023-05-0921:10 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001823239-23-000039 |
| 2023-05-0820:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001823239-23-000037 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.